跳至主要内容
临床试验/NCT02246036
NCT02246036已完成不适用

Clinical Trial to Assess the Tolerance and the Safety of a Duodenal Tube Monitoring the Microcirculation in 10 Critically Ill Patients.

Advanced Perfusion Diagnostics6 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2014年12月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
10
试验地点
6
主要终点
Absence of duodenal lesions

研究概览

简要总结

For Intensive Care Units (ICU) patients, Multiple Organ Dysfunction Syndrome (MODS) is a very common complication yielding high morbidity and mortality. Inadequate regional perfusion of certain organs (gut, kidney, liver, etc) often caused by shock is the main cause of MODS. Current practice uses cardiac output data and blood pressure to manage shock but there are still lacks of information about the regional perfusion. This leads to late MODS diagnostics preventing the implementation of adequate treatment.

Gut perfusion monitoring seems to be a good target to assess the microcirculation but, nowadays, no practical methods or devices are available to measure the gut perfusion, and the current monitoring methods are not specific (CO, BP, OPS-SDF, PCO2, etc).

"MC Monitor" trial is a prospective, multi-center pilot study, enrolling 10 patients.

The probe will be used by intensivists on ICU patients with a risk of shock and requiring mechanical ventilation.

The probe will be placed in the patient with an endoscopic procedure by a gastroenterologist (standard procedure for post-pyloric tubes placement). This procedure will be used to assess the status of the gut mucosa prior to the placement of the APD probe.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18 years of age or more,
  • Male or female,
  • ICU patient, on vasoactive amines, under mechanical ventilation,
  • Stable hemodynamic status,
  • Life expectancy expected to exceed 72 hours,
  • Length of ICU stay greater than 5 days,
  • Willing to participate and signed informed consent,
  • Affiliation to the French social security system.

排除标准

  • Pregnant or lactating woman,
  • Ongoing enteral nutrition,
  • Risk of gastrointestinal ischemia,
  • History of pharyngeal surgery surgery, esophageal surgery, radiotherapy of mediastinal area,
  • Known ear-nose-throat malignant disease,
  • Unexplored dysphagia,
  • Known recent gastrointestinal suture,
  • Esophageal varices,
  • Abdominal pain,
  • Unstable cervical fracture,
  • Moribund patient,
  • Active participation in another investigational protocol within the past 30 days,
  • Subject legally protected, under legal guardianship, deprived of his/her liberty by judicial or administrative decision.

结局指标

主要结局

Absence of duodenal lesions

时间窗: 24 hours

Duodenal lesions are defined as visible alterations of the duodenum.

次要结局

  • Signal-to-noise ratio of the APD probe(24 hours)

研究者

发起方
Advanced Perfusion Diagnostics
申办方类型
Industry
责任方
Sponsor

研究点 (6)

Loading locations...

相似试验

Tolerance and Safety of a Duodenal Probe Monitoring... | 临床试验